Skip to main content
. 2021 Dec 30;100(52):e27411. doi: 10.1097/MD.0000000000027411

Table 1.

Summary of characteristics of randomized studies.

No. of patients Event number: MACE
Author (yr) Study design Clinical setting (ACS/Mixed) Follow-up (mo) Nationality Definition of composite outcome of MACE PPI PPI Control PPI Control
Bhatt et al (2010)[17] RCT Mixed 3.5 Multinational, 15 countries Composite of CV death, nonfatal MI, CABG, PCI, stroke) O 1876 1885 55 54
Yano et al (2012)[13] RCT ACS 12 Japan MI, revascularization, rehospitalization for ACS O 65 65 8 12
Ng et al (2012)[14] RCT ACS 4.5 Hong Kong CV mortality, nonfatal MI, stroke revascularization, revascularization E 163 148 7 5
Zhang et al (2015)[15] RCT ACS 6 China MI, revascularization, rehospitalization forACS L 53 51 7 5
Wei et al (2016)[16] RCT ACS 6 China cardiac death, MI, HF severe arrhythmia, angina P 117 80 48 33
Ren et al (2011)[12] RCT ACS 1 China CV mortality, nonfatal MI, strokerevascularization O 86 86 22 22